Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. [electronic resource]
Producer: 20021118Description: 1078-81 p. digitalISSN:- 0007-1048
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD19 -- blood
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Autoimmune Diseases -- drug therapy
- Child
- Combined Modality Therapy
- Humans
- Immunoglobulin G -- blood
- Lymphoproliferative Disorders -- drug therapy
- Male
- Mutation
- Platelet Count
- Proteins -- genetics
- Rituximab
- TNF Receptor-Associated Factor 6
- Thrombocytopenia -- drug therapy
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.